×
Depression, Obesity, and Metabolic Syndrome: Prevalence and Risks of Comorbidity in a Population-Based Representative Sample of Mexican Americans PDF
$ 40.00
Depression, Obesity, and Metabolic Syndrome: Prevalence and Risks of Comorbidity in a Population-Based Representative Sample of Mexican Americans PDF quantity
$ 40.00
×
Efficacy and Tolerability of Once-Daily Venlafaxine Extended Release (XR) in Outpatients With Major Depression PDF
$ 40.00
Efficacy and Tolerability of Once-Daily Venlafaxine Extended Release (XR) in Outpatients With Major Depression PDF quantity
$ 40.00
×
Complementary and Alternative Treatments for Late-Life Depression, Anxiety, and Sleep Disturbance: A Review of Randomized Controlled Trials PDF
$ 40.00
Complementary and Alternative Treatments for Late-Life Depression, Anxiety, and Sleep Disturbance: A Review of Randomized Controlled Trials PDF quantity
$ 40.00
×
Increased Silent Brain Infarction Accompanied With High Prevalence of Diabetes and Dyslipidemia in Psychiatric Inpatients: A Cross-Sectional Study PDF
$ 40.00
Increased Silent Brain Infarction Accompanied With High Prevalence of Diabetes and Dyslipidemia in Psychiatric Inpatients: A Cross-Sectional Study PDF quantity
$ 40.00
×
A Survey of Medically Self-Sabotaging Behaviors Among Perpetrators of Partner Violence PDF
$ 40.00
A Survey of Medically Self-Sabotaging Behaviors Among Perpetrators of Partner Violence PDF quantity
$ 40.00
×
Are Mood Disorders and Obesity Related? A Review for the Mental Health Professional PDF
$ 40.00
Are Mood Disorders and Obesity Related? A Review for the Mental Health Professional PDF quantity
$ 40.00
×
Prediction of Response to Paroxetine and Venlafaxine by Serotonin-Related Genes in Obsessive-Compulsive Disorder in a Randomized, Double-Blind Trial PDF
$ 40.00
Prediction of Response to Paroxetine and Venlafaxine by Serotonin-Related Genes in Obsessive-Compulsive Disorder in a Randomized, Double-Blind Trial PDF quantity
$ 40.00
×
A Randomized, Double-Blind Comparison of Olanzapine/Fluoxetine Combination, Olanzapine, and Fluoxetine in Treatment-Resistant Major Depressive Disorder PDF
$ 40.00
A Randomized, Double-Blind Comparison of Olanzapine/Fluoxetine Combination, Olanzapine, and Fluoxetine in Treatment-Resistant Major Depressive Disorder PDF quantity
$ 40.00
×
Quetiapine in the Treatment of Anxiety in Patients With Bipolar I or II Depression: A Secondary Analysis From a Randomized, Double-Blind, Placebo-Controlled Study. PDF
$ 40.00
Quetiapine in the Treatment of Anxiety in Patients With Bipolar I or II Depression: A Secondary Analysis From a Randomized, Double-Blind, Placebo-Controlled Study. PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart
